Trial NCT01636609

View at ClinicalTrials.gov 
Org. Study IDs: 2011-0188
Secondary IDs: 2011-0188 NCI-2018-01817 P30CA016672

Last trial update was posted on 2020-04-13

MeSH Interventions

Azacitidine Cytarabine Glycine Tosedostat

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

Acute Myeloid Leukemia High Risk Myelodysplastic Syndrome

Stopping Reasons

In 2013 the FDA put a temporary hold on the trial and the Phase II portion of this study was cancelled.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID